Virtu Financial’s Bionano Genomics BNGO Stock Holding History

Virtu Financial’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-13,751	Closed	-$16K	–	1626
2026 Q1	$16K	Buy	+13,751	New	+$17.6K	﹤0.01%	1419
2024 Q2	–	Sell	-548	Closed	-$36K	–	1337
2024 Q1	$36K	Buy	+548	New	+$40.9K	﹤0.01%	1074
2023 Q3	–	Sell	-397	Closed	-$145K	–	1335
2023 Q2	$145K	Buy	397 +299	+305%	+$135K	0.01%	916
2023 Q1	$65K	Sell	98 -333	-77%	-$296K	0.01%	1056
2022 Q4	$378K	Buy	431 +323	+299%	+$406K	0.05%	378
2022 Q3	$119K	Buy	+108	New	+$143K	0.01%	1040
2021 Q4	–	Sell	-165	Closed	-$544K	–	1726
2021 Q3	$544K	Sell	165 -352	-68%	-$1.23M	0.05%	426
2021 Q2	$2.27M	Buy	+517	New	+$2.04M	0.22%	61
2020 Q4	–	Sell	-421	Closed	-$164K	–	1450
2020 Q3	$164K	Buy	+421	New	+$163K	0.03%	628
2019 Q4	$75K	Buy	102 +69	+209%	+$40.3K	0.01%	1136
2019 Q3	$14K	Buy	+33	New	+$35.9K	﹤0.01%	1321

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Virtu Financial's BNGO Position: Q2 2026 in Review

Virtu Financial sold out of Bionano Genomics (BNGO) in Q2 2026, closing a stake of 13,751 shares — an estimated $16K sold.

Virtu Financial first reported a position in BNGO in Q3 2019 and held it in 11 quarters. The position peaked at $2.27M in Q2 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

Virtu Financial reported no remaining Bionano Genomics position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 13,751 Bionano Genomics shares in Q2 2026, an estimated $16K.
Virtu Financial first reported a position in Bionano Genomics in Q3 2019 and held it in 11 quarters.
Virtu Financial's Bionano Genomics position peaked at $2.27M in Q2 2021.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.